Popular topics to explore
SENores PHARMA | FY25 ANNUAL REPORT — WHAT INVESTORS
SENores PHARMA | FY25 ANNUAL REPORT — WHAT INVESTORS SHOULD KNOW 🔍
Senores Pharmaceuticals delivered a breakout year in its first year as a listed company.
📈 Revenue +92% YoY SENORES
🔥 EBITDA +148% YoY
📊 EBITDA Margin: 27% | +640 bp…
SENΟRES PHARMA | FY25 ANNUAL REPORT 🔍
SENΟRES PHARMA | FY25 ANNUAL REPORT 🔍
SENORES
A strong growth story — but with a few things investors should watch.
Senores Pharmaceuticals delivered a breakout year as it entered the public markets.
📈 Revenue +92% YoY
🔥 EBITDA +148%…
🚀 50 Stocks With Strong Q1 FY27 Concall Commentary 📊🔥
🚀 50 Stocks With Strong Q1 FY27 Concall Commentary 📊🔥
!SGMART SBCL
🔹 #SGMART — 🚀 118% EBITDA growth outlook; ₹300 Cr EBITDA target for FY27
🔹 #SENORES — 💊 Targeting 30–40% revenue growth and 50–60% PAT growth in FY27
🔹 #SAKAR…
Senores Pharma: 56% PAT Growth + Bullish Rebound — 22% Upside on the Radar
SENORES . is a pharmaceutical company focused on developing and manufacturing complex generics and specialty pharmaceutical products for regulated and emerging markets. The company has built capabilities across product development, manufac…
30th Jul · SEBI-Registered Analyst
"Invest like HNIs" by Clovek · 30th Jul
SENORES announced Q1FY27 results Consolidated Financial Highlights:
SENORES announced Q1FY27 results Consolidated Financial Highlights:
The company reported a Revenue From Operations of Rs 180.21 crore in Q1FY27, representing a YoY increase of 35.95% from Rs 132.56 crore in Q1FY26, and a QoQ growth of 2.8…
SENORES
Fundamental: Revenue +53.4% YoY | PAT +77.3% YoY | P/E 50.6x vs sector 46.4x (slight premium; near own 10Y avg) | Upside 22.2% | Operating Margin 34.2% (+987 bps) | ROCE 14.4% | Rank #5/51 peers | Rating 8.50 Technical: Strong bullish tre…
NETWEB Stocks up more than +100% in last 1 year:
Swan Defence: +978%
Cupid: +852%
Sterlite Tech.: +518%
Sigma Advanced System: +515%
Modern Insulator: +462%
V-Marc India: +445%
MTAR Technologie: +388%
Midwest Gold: +387%
CIAN Agro: +337…
SENORES
SENORES Fundamental: Revenue +53.4% YoY | PAT +77.3% YoY | P/E 38.1x vs sector 43.1x (11% discount) | Upside 27.2% | Operating Margin 34.2% | ROCE 14.4% | Rank #2/51 peers | Rating 8.88
Technical: Above all key EMAs sustained bullish st…
SENORES PHARMA TARGETS STRONG REVENUE GROWTH IN FY27 WITH NEW PRODUCT LAUNCHES
Gujarat-based pharmaceutical company SENORES is guiding for a 30–40% revenue growth this fiscal year, with profit after tax expected to expand at an even sharper 50–60% clip. This projection is based on a pipeline of 51 approved ANDAs, 30…
ADANIPORTS STOCKS WATCHLIST
Positives
Adani Ports- Sets 1bn tons cargo target by 2030
WIPRO-To acquire 100% stake in Mindsprint for $375 Mn
Maruti Suzuki-To expand this network to around 8,000 touchpoints by FY 2030–31
HDFC Bank-Ap…
Strategic Joint Venture in the United States - Senores Pharmaceuticals Ltd
Code BSE: 544319 NSE: SENORES
Senores Pharmaceuticals, Inc. announces Strategic Joint Venture in the United States, positioning the group for U.S. Federal and Defense Sector Supplies
"Amerisyn is a major milestone for Senores. This wil…
Stocks to Watch – Market Update
Positives
HDFCBANK : Received RBI approval to acquire up to 9.5% stake in INDUSINDBK , providing strategic optionality.
BL Kashyap: Secured a ₹616 crore order, strengthening its order book visibility.
Zydus Life: USFDA accepted a drug…
Launch of Deferiprone Tablets USP - Senores Pharmaceuticals Ltd
Code BSE: 544319 NSE: SENORES
Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg which will be marketed by Dr. Reddy’s Laboratories Inc. in the US market
“We are pleased to ad…
StockToWatch
Positives
TATAPOWER : Won transmission order from REC Power.
VEDL : Declared successful bidder for the Genjana critical minerals block
NBCC, Astra Microwave: Order wins.
Gail: PNGRB approved zonal tariff for GAIL’s pipeline
Honasa Co…
25 strong stocks in a weak market but on dip!📊 1. Travel Food Services 2. M&M 3. BSE 4. MCX 5. NYKAA 6. Transrail 7. Pace Digitek 8. Lumax Auto 9. India Glycols 10. Reliance 11. Senores Pharma 12. Belrise 13. Polycab 14. Eicher Motors 15.…
BSE 15 Momentum Stocks Breaking into New Highs
Pure momentum. Pure strength. Studying these helps you spot future leaders
1. Aditya Infotech
2. BSE
3. Interarch
4. MBEL
5. Vintage Coffee
6. Pondy Oxides
7. MCX
8. Atlanta Electricals
9. CC…
SENORES
Senores Pharmaceuticals has achieved a significant milestone as its stock price reached an all-time high of Rs. 830.3 on November 7, 2025. This remarkable performance underscores the company's strong position within the pharmaceuticals and…
SENORES
Senores Pharmaceuticals has reached a significant milestone by hitting a new 52-week high of Rs. 755 on October 16, 2025. This marks a notable achievement for the small-cap company in the Pharmaceuticals and Biotechnology sector. The stock…
Senores Pharmaceuticals Latest Updates
SENORES Financial and Operational Highlights
Investment in US Subsidiary: Senores Pharmaceuticals announced a $2 million investment in its wholly-owned US subsidiary, Senores Pharmaceuticals Inc. (SPI), through a rights issue. The capital…
🖊️ Senores Pharma Daily – At the Edge of Exhaustion?
SENORES
📉 1. Rising Channel Resistance Respected
The stock recently touched the upper boundary of the red rising channel, a level that has historically triggered corrections.
Today's candle shows rejection from this line, hinting at short…
